Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: a test …

K Intawong, S Chariyalertsak, K Chalom… - The Lancet Regional …, 2023 - thelancet.com
Summary Background The Coronavirus disease 2019 (COVID-19) pandemic has evolved
quickly, with numerous waves of different variants of concern resulting in the need for …

Treatment with integrase inhibitors alters SARS‐CoV‐2 neutralization levels measured with HIV‐based pseudotypes in people living with HIV

E De La Torre‐Tarazona… - Journal of Medical …, 2023 - Wiley Online Library
The presence of neutralizing antibodies (NAbs) is a major correlate of protection for severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Thus, different in vitro …

Vaccine-induced SARS-CoV-2 antibody response: the comparability of S1-specific binding assays depends on epitope and isotype discrimination

S Schest, C Langer, Y Stiegler, B Karnuth… - Frontiers in …, 2023 - frontiersin.org
Background Quantification of the SARS-CoV-2-specific immune response by serological
immunoassays is critical for the management of the COVID-19 pandemic. In particular …

[HTML][HTML] Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants

J García-Pérez, AM Borobia, M Pérez-Olmeda… - Iscience, 2024 - cell.com
CombiVacS study has demonstrated a strong immune response of the heterologous
ChAdOx1-S/BNT162b2 vaccine combination. The primary outcomes of the study were to …

[HTML][HTML] Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021–2022

D Yoon, K Jung, JH Kim, HY Ko… - Emerging Infectious …, 2024 - pmc.ncbi.nlm.nih.gov
We conducted a self-controlled case series study to investigate the association between
COVID-19 vaccination and facial palsy (FP) in South Korea. We used a large immunization …

[PDF][PDF] Bdigital

AMB Pérez - 2023 - scren.eu
La Plataforma ISCIII de Soporte para la Investigación Clínica, conocida como SCReN (del
inglés “Spanish Clinical Research Network”) es una de las tres Plataformas ISCIII de apoyo …